spiperone has been researched along with fluorine in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (95.24) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fowler, JS; Logan, J; Shiue, CY; Wolf, AP | 1 |
Arnett, CD; Fowler, JS; Logan, J; Shiue, CY; Watanabe, M; Wolf, AP | 1 |
Arnett, CD; Fowler, JS; Shiue, CY; Watanabe, M; Wolf, AP | 1 |
Böcher-Schwarz, HG; Coenen, HH; Heiss, WD; Laufer, P; Pawlik, G; Stöcklin, G; Wienhard, K | 1 |
Brodack, JW; Chi, DY; Katzenellenbogen, JA; Kilbourn, MR; Welch, MJ | 1 |
Cohen, RM; Eckelman, WC; Finn, RD; Kiesewetter, DO; Larson, SM | 1 |
Kilbourn, MR; Larson, KB; Markham, J; Mintun, MA; Perlmutter, JS; Raichle, ME; Welch, MJ | 1 |
Arnett, CD; Christman, DR; Fowler, JS; MacGregor, RR; Shiue, CY; Smith, MR; Wolf, AP | 1 |
Fowler, JS; MacGregor, RR; Schlyer, DJ; Shiue, CY; Wolf, AP | 1 |
Arnett, CD; Fowler, JS; McPherson, DW; Shiue, CY; Wolf, AP; Zecca, L | 1 |
Arnett, CD; Fowler, JS; Halldin, C; Långström, B; MacGregor, RR; Shiue, CY; Wagner, HN; Wolf, AP | 1 |
Brodack, JW; Chi, DY; Katzenellenbogen, JA; Kilbourn, MR; Mathias, CJ; Welch, MJ | 1 |
Laufer, P; Moerlein, SM; Stöcklin, G | 1 |
Arnett, CD; Fowler, JS; McPherson, DW; Shiue, CY; Wolf, AP | 1 |
Wagner, HN | 1 |
Dence, CS; Kilbourn, MR; Maeda, M; Saji, H; Tewson, TJ; Welch, MJ | 1 |
Eckelman, WC; Gibson, RE | 1 |
Kilbourn, MR; Mintun, MA; Raichle, ME; Welch, MJ; Wooten, GF | 1 |
Kilbourn, MR; Mintun, MA; Raichle, ME; Welch, MJ | 1 |
Kilbourn, MR; Mathias, CJ; Mintun, MA; Raichle, ME; Welch, MJ | 1 |
Fukumura, T; Maeda, M; Obana, N; Sasaki, S; Takao, F; Takehara, S; Watanabe, K | 1 |
21 other study(ies) available for spiperone and fluorine
Article | Year |
---|---|
Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.
Topics: Animals; Antipsychotic Agents; Benperidol; Butaclamol; Cerebellum; Corpus Striatum; Female; Fluorine; Haloperidol; Kinetics; Models, Biological; Papio; Radioisotopes; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed | 1987 |
Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.
Topics: Animals; Benperidol; Brain; Butaclamol; Butyrophenones; Female; Fluorine; Haloperidol; Isotope Labeling; Male; Papio; Radioisotopes; Rats; Spiperone; Time Factors; Tissue Distribution; Tomography, Emission-Computed | 1985 |
Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone.
Topics: Antipsychotic Agents; Benperidol; Butyrophenones; Fluorine; Haloperidol; Isotope Labeling; Radioisotopes; Spiperone | 1985 |
3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
Topics: Animals; Cerebellum; Corpus Striatum; Fluorine; Male; Mice; Papio; Radioisotopes; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Tomography, Emission-Computed | 1987 |
Synthesis of no-carrier-added N-([18F]fluoroalkyl)spiperone derivatives.
Topics: Chromatography, High Pressure Liquid; Fluorine; Indicators and Reagents; Radioisotopes; Spiperone; Structure-Activity Relationship | 1986 |
Syntheses and D2 receptor affinities of derivatives of spiperone containing aliphatic halogens.
Topics: Animals; Fluorine; Indicators and Reagents; Magnetic Resonance Spectroscopy; Radioisotopes; Receptors, Dopamine; Spectrophotometry, Infrared; Spiperone; Structure-Activity Relationship | 1986 |
Strategies for in vivo measurement of receptor binding using positron emission tomography.
Topics: Animals; Binding Sites; Brain; Female; Fluorine; Kinetics; Models, Biological; Papio; Radioisotopes; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed | 1986 |
Improved delineation of human dopamine receptors using [18F]-N-methylspiroperidol and PET.
Topics: Adult; Brain; Caudate Nucleus; Fluorine; Frontal Lobe; Half-Life; Humans; Kinetics; Male; Putamen; Radioisotopes; Radioligand Assay; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed | 1986 |
Fluorine-18-N-methylspiroperidol: radiolytic decomposition as a consequence of high specific activity and high dose levels.
Topics: Chromatography, High Pressure Liquid; Fluorine; Hydrogen-Ion Concentration; Isotope Labeling; Kinetics; Quality Control; Radiochemistry; Radioisotopes; Solutions; Spiperone; Tomography, Emission-Computed | 1987 |
No-carrier-added fluorine-18-labeled N-methylspiroperidol: synthesis and biodistribution in mice.
Topics: Animals; Brain; Butyrophenones; Female; Fluorine; Isotope Labeling; Mice; Radioisotopes; Radioligand Assay; Radionuclide Imaging; Receptors, Dopamine; Spiperone; Tissue Distribution | 1986 |
A direct comparison of the brain uptake and plasma clearance of N-[11C]methylspiroperidol and [18F]N-methylspiroperidol in baboon using PET.
Topics: Animals; Brain; Carbon Radioisotopes; Female; Fluorine; Metabolic Clearance Rate; Papio; Radioisotopes; Radionuclide Imaging; Spiperone | 1986 |
Biodistribution of N-alkyl and N-fluoroalkyl derivatives of spiroperidol; radiopharmaceuticals for PET studies of dopamine receptors.
Topics: Alkylation; Animals; Blood-Brain Barrier; Brain; Fluorine; Radioisotopes; Rats; Receptors, Dopamine; Spiperone; Structure-Activity Relationship; Tissue Distribution | 1986 |
Effect of lipophilicity on the in vivo localization of radiolabelled spiperone analogues.
Topics: Animals; Brain Chemistry; Bromine; Butyrophenones; Carbon Radioisotopes; Chemical Phenomena; Chemistry; Female; Fluorine; Molecular Weight; Radioisotopes; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1985 |
[18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain.
Topics: Animals; Brain; Butyrophenones; Female; Fluorine; Male; Papio; Radioisotopes; Rats; Spiperone; Time Factors; Tomography, Emission-Computed | 1985 |
Imaging CNS receptors: the dopaminergic system.
Topics: Animals; Antipsychotic Agents; Apomorphine; Binding Sites; Brain; Carbon Radioisotopes; Deoxyglucose; Dyskinesia, Drug-Induced; Fluorine; Haloperidol; Humans; Parkinson Disease; Radioisotopes; Receptors, Dopamine; Schizophrenia; Spiperone; Tomography, Emission-Computed; Tritium | 1984 |
Carrier-added and no-carrier-added syntheses of [18F]spiroperidol and [18F]haloperidol.
Topics: Butyrophenones; Fluorine; Haloperidol; Isotope Labeling; Radioisotopes; Spiperone | 1984 |
Re: Receptor binding of F-18 haloperidol and spiroperidol.
Topics: Animals; Butyrophenones; Fluorine; Haloperidol; Radioisotopes; Radioligand Assay; Receptors, Dopamine; Spiperone | 1984 |
A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography.
Topics: Animals; Binding Sites; Blood-Brain Barrier; Brain; Fluorine; Models, Neurological; Papio; Radioisotopes; Receptors, Drug; Spiperone; Tomography, Emission-Computed | 1984 |
[18F]spiroperidol: a radiopharmaceutical for the in vivo study of the dopamine receptor.
Topics: Animals; Butyrophenones; Cerebellum; Corpus Striatum; Fluorine; Haloperidol; Papio; Radioisotopes; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed | 1984 |
Comparison in animal models of 18F-spiroperidol and 18F-haloperidol: potential agents for imaging the dopamine receptor.
Topics: Animals; Brain; Butyrophenones; Fluorine; Haloperidol; Papio; Radioisotopes; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1983 |
New fluorinated dopamine D2 ligands with benzofuran skeleton. The synthesis and in vitro evaluation.
Topics: Animals; Benzofurans; Binding Sites; Corpus Striatum; Dopamine; Fluorine; In Vitro Techniques; Rats; Receptors, Dopamine D2; Spiperone; Structure-Activity Relationship; Tomography, Emission-Computed | 1993 |